Medicare Advantage
Date Range
Score Range
Highlights high denial rates in Medicare Advantage plans as evidence of profit-driven healthcare decisions
The story includes a strong expert quote condemning the denial rates as 'staggering' and frames denials as prioritizing profit over medical need, with emotive language and no counter-narrative from insurers or the administration.
“These denial rates are quite staggering,” said Miranda Yaver, an assistant professor of health policy and management at the University of Pittsburgh. “It’s another data point that reinforces what a lot of Americans have already been articulating a lot of frustration about — which is that healthcare decisions are being made with profit rather than medical necessity in mind.””
Portrays Medicare Advantage plans as systematically denying necessary care for financial gain
The article emphasizes high denial rates, wide variation between insurers, and a 95% reversal rate on appeal, suggesting systemic failure. It highlights expert criticism framing denials as profit-driven rather than clinically justified.
“These denial rates are quite staggering... healthcare decisions are being made with profit rather than medical necessity in mind.”